Exploring ovarian cancer cell resistance to rhenium anticancer complexes.

Marker, Sierra C; King, A Paden; Swanda, Robert V; Vaughn, Brett; Boros, Eszter; Qian, Shu-Bing; Wilson, Justin J

Marker, Sierra C; King, A Paden; Swanda, Robert V; Vaughn, Brett; Boros, Eszter; Qian, Shu-Bing; Wilson, Justin J.

Afiliación

Marker SC; Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States.
King AP; Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States.
Swanda RV; Division of Nutritional Sciences, Cornell University, Ithaca, New York, 14853, United States.
Vaughn B; Department of Chemistry, Stony Brook University, Stony Brook, New York, 11794, United States.
Boros E; Department of Chemistry, Stony Brook University, Stony Brook, New York, 11794, United States.
Qian SB; Division of Nutritional Sciences, Cornell University, Ithaca, New York, 14853, United States.
Wilson JJ; Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States.

Angew Chem Weinheim Bergstr Ger ; 132(32): 13493-13502, 2020 Aug 03.

Article en En | MEDLINE | ID: mdl-34366495

Palabras clave

bioinorganic chemistry; cancer; drug resistance; gene expression; rhenium

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Angew Chem Weinheim Bergstr Ger Asunto de la revista: BIOFISICA / QUIMICA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google